Clin2
NCT04589624Possibly a fitRecruiting

MRI scan to monitor response in head and neck cancers

Thyroid Gland Carcinoma

Treatments studied

Part of Cancer, Hormones & metabolism clinical trials.

This Phase 1 study tests an investigational MRI scan (hpMRI) to help doctors see how thyroid cancer and other head-and-neck cancers respond to treatment like radiation or other medicines. If you’re eligible, the scan may help track treatment effects more closely, though it’s still being studied for this purpose.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
42 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Be able to sign informed consent and understand the study is experimental
  • Have thyroid cancer or another cancer in the head and neck that is planned for treatment
  • Be able to safely get an MRI scan (no devices that block MRI)
  • Do not have severe claustrophobia that prevents MRI
  • No allergy to Gadavist contrast dye and kidney function must be enough for contrast (eGFR 30 or higher)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03483337Recruiting
MRI scan tests new markers for head and neck cancers

This trial tests special MRI scans to find warning signs of cancer that has returned or spread in the head and neck area. It may help doctors see these changes more clearly, which could improve treatment planning.

New York, New York
NCT03739411Recruiting· Phase 1
MRI scan with a special agent to assess brain tumors

This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.

San Francisco, California
NCT05599048Recruiting· Phase 1/Phase 2
MRI scan using a special sugar to study solid tumors

This early-phase study tests whether a special MRI scan with injected labeled “pyruvate” can act as a biomarker (a measurable sign) for advanced solid tumor activity. It may help doctors see tumor metabolism over time and better track how treatment is affecting cancer.

San Francisco, California
NCT05805358Not yet recruiting· Phase 2
MRI scan to help test immunotherapy for gynecologic cancers

This Phase 2 study uses a special MRI scan (hyperpolarized carbon-13) to look at how well immunotherapy works in gynecologic cancers. You may be able to help researchers better understand treatment response, if you meet the study health and scan-safety requirements.

Taoyuan City, Guishan District
NCT06085781Recruiting
MRI and tumor study for head and neck cancer patients

This trial uses special MRI scans to look at your head, neck, and tumor environment before treatment. It aims to find better ways to understand your cancer and guide care.

Toronto, Ontario
NCT03067467Recruiting
MRI scan study of brain tumors using special carbon imaging

This trial uses a special MRI scan that shows how “metabolism” (how cells use fuel) differs in brain tumors. It may help researchers better understand tumor biology and how tumors may respond to treatment, without using chemotherapy or radiation as part of the study.

Dallas, Texas

Hear when a new Thyroid Gland Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.